199 related articles for article (PubMed ID: 23478628)
1. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.
Dmitriev AA; Rudenko EE; Kudryavtseva AV; Krasnov GS; Gordiyuk VV; Melnikova NV; Stakhovsky EO; Kononenko OA; Pavlova LS; Kondratieva TT; Alekseev BY; Braga EA; Senchenko VN; Kashuba VI
Biomed Res Int; 2014; 2014():735292. PubMed ID: 24977159
[TBL] [Abstract][Full Text] [Related]
4. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.
Senchenko VN; Anedchenko EA; Kondratieva TT; Krasnov GS; Dmitriev AA; Zabarovska VI; Pavlova TV; Kashuba VI; Lerman MI; Zabarovsky ER
BMC Cancer; 2010 Mar; 10():75. PubMed ID: 20193080
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
7. NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.
Kashuba V; Dmitriev AA; Krasnov GS; Pavlova T; Ignatjev I; Gordiyuk VV; Gerashchenko AV; Braga EA; Yenamandra SP; Lerman M; Senchenko VN; Zabarovsky E
Int J Mol Sci; 2012 Oct; 13(10):13352-77. PubMed ID: 23202957
[TBL] [Abstract][Full Text] [Related]
8. [Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome].
Pavlova TV; Kashuba VI; Muravenko OV; Yenamandra SP; Ivanova TA; Zabarovskaia VI; Rakhmanaliev ER; Petrenko LA; Pronina IV; Loginov VI; Iurkevich OIu; Kiselev LL; Zelenin AV; Zabarovskiĭ ER
Mol Biol (Mosk); 2009; 43(2):339-47. PubMed ID: 19425501
[TBL] [Abstract][Full Text] [Related]
9. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
11. [Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors].
Maliukova AV; Loginov VI; Khodyrev DS; Kadyrova EL; Pronina IV; Ivanova TA; Kiselev FL; Zabarovskiĭ NP; Braga EA
Mol Biol (Mosk); 2004; 38(6):1005-13. PubMed ID: 15612586
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
[TBL] [Abstract][Full Text] [Related]
13. [Identification of changes in gene loci potentially associated with cervical cancer using NotI microarrays].
Kashuba VI; Skripkina IIa; Saraev DV; Gordiiuk VV; Vinnitskaia AB; Tsyba LA; Pogrebnoĭ PV; Blinov VM; Zabarovskiĭ ER; Ryndich AV
Ukr Biokhim Zh (1999); 2006; 78(2):113-20. PubMed ID: 17100293
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
15. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
Agathanggelou A; Honorio S; Macartney DP; Martinez A; Dallol A; Rader J; Fullwood P; Chauhan A; Walker R; Shaw JA; Hosoe S; Lerman MI; Minna JD; Maher ER; Latif F
Oncogene; 2001 Mar; 20(12):1509-18. PubMed ID: 11313894
[TBL] [Abstract][Full Text] [Related]
16. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.
Dmitriev AA; Rosenberg EE; Krasnov GS; Gerashchenko GV; Gordiyuk VV; Pavlova TV; Kudryavtseva AV; Beniaminov AD; Belova AA; Bondarenko YN; Danilets RO; Glukhov AI; Kondratov AG; Alexeyenko A; Alekseev BY; Klein G; Senchenko VN; Kashuba VI
Dis Markers; 2015; 2015():241301. PubMed ID: 26491211
[TBL] [Abstract][Full Text] [Related]
18. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
[TBL] [Abstract][Full Text] [Related]
19. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
[TBL] [Abstract][Full Text] [Related]
20. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
